News from the healthcare data industry
DEERFIELD, Ill. & SAN FRANCISCO, June 15, 2023 — Walgreens and Freenome today announced a multi-year relationship to advance clinical studies of Freenome’s blood-based tests for the early detection of cancer....
– The company is pioneering a new approach for the development and improvement of its test platform by combining multiomics with real-world data – The Sanderson Study underscores Freenome’s commitment to...
The company’s Learning Health Network teams with Elligo Health Research and Freenome to Advance Early Cancer Detection KANSAS CITY, Mo. – May 18, 2022 – Cerner Corporation (NASDAQ: CERN), Elligo Health Research® and Freenome are collaborating...
– Freenome surpasses $1B in total funding with major investment from Roche – Freenome to expand platform to other cancers with dedicated multicancer and real-world data studies NEWS PROVIDED BYFreenome...